REVERSE INTERFERENCE METHOD FOR MEASUREMENT OF HOG-CHOLERA VIRUS (HCV) AND ANTI-HCV ANTIBODY

被引:2
|
作者
TSUCHIYA, Y [1 ]
UCHIMURA, A [1 ]
TAJIKA, H [1 ]
SAKAMOTO, K [1 ]
FURUYA, T [1 ]
SATO, K [1 ]
NANBA, K [1 ]
MIURA, Y [1 ]
机构
[1] MATSUMOTO LIVESTOCK HYG SERV CTR,MATSUMOTO,NAGANO 390,JAPAN
来源
JOURNAL OF VETERINARY MEDICAL SCIENCE | 1993年 / 55卷 / 02期
关键词
END METHOD; GPE-; STRAIN; HOG CHOLERA VIRUS; INTERFERON; VESICULAR STOMATITIS VIRUS;
D O I
10.1292/jvms.55.233
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
A new procedure was developed for the assay of the hog cholera virus (HCV) and anti-HCV antibody. Initially, the suppression effect of HCV on interferon (IFN) by HCV production was confirmed. Swine kidney cell cultures preinfected with HCV produced no IFN, even following the addition of IFN inducers. However the sensitivity of the cell to IFN was not influenced by the infection with this virus. Based on these results, a new method, named reverse interference method, was established. In this method, infective titer of HCV was determined by the appearance of cell pathogenic effects (CPE) induced by vesicular stomatitis virus (VSV), which is caused by the suppression effect on the heterologous interference of GPE- strain of HCV against VSV infection in swine kidney cell cultures. This method showed nearly the same sensitivity as the END method. There was no difference in the infective titer of HCV and antibody titer against HCV as estimated by this method and the END method. The reverse interference method had advantages in rapidity and objectivity compared with the END method.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 50 条
  • [31] Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users
    Pirisi, M
    Toniutto, P
    Fabris, C
    Lombardelli, T
    Falleti, E
    Tisminetzky, SG
    Baralle, F
    Bartoli, E
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (05) : 423 - 427
  • [32] The immunologically silent patient: A blood donor with HCV-RNA without detectable anti-HCV antibody
    Durand, F
    Danic, B
    Tardivel, R
    Beauplet, A
    [J]. TRANSFUSION, 1999, 39 (10) : 94S - 94S
  • [33] Hepatitis C virus (HCV) genotypes, anti-HCV-IGM core and liver histology in a cohort of asymptomatic anti-HCV positive subjects
    Belloni, G
    Giangregorio, F
    Ferrari, L
    Barbieri, F
    Balduzzi, C
    Mazzucco, M
    Poma, R
    Barbarini, G
    Klersy, C
    [J]. HEPATOLOGY, 1996, 24 (04) : 1423 - 1423
  • [34] PREVALENCE OF ANTI-HCV ANTIBODY IN BLOOD-DONORS IN THE TOKYO AREA
    WATANABE, J
    MINEGISHI, K
    MITSUMORI, T
    ISHIFUJI, M
    OGUCHI, T
    UEDA, M
    TOKUNAGA, E
    TANAKA, E
    KIYOSAWA, K
    FURUTA, S
    KATAYAMA, T
    KUO, G
    CHOO, QL
    HOUGHTON, M
    NISHIOKA, K
    [J]. VOX SANGUINIS, 1990, 59 (02) : 86 - 88
  • [35] Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection
    Laperche, S
    Le Marrec, N
    Girault, A
    Bouchardeau, F
    Servant-Delmas, A
    Maniez-Montreuil, M
    Gallian, P
    Levayer, T
    Morel, P
    Simon, N
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) : 3877 - 3883
  • [36] Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients
    Trimoulet, P.
    Belzunce, C.
    Faure, M.
    Wittkop, L.
    Reigadas, S.
    Dupon, M.
    Ragnaud, J-M
    Fleury, H.
    Neau, D.
    [J]. HIV MEDICINE, 2011, 12 (08) : 506 - 509
  • [37] ONE-YEAR EVOLUTION OF ANTI-HCV ANTIBODY IN A HEMODIALYSIS POPULATION
    SILVA, JG
    OLIVEIRA, C
    FRAZAO, JM
    PIRES, C
    CARRERA, F
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (06) : 1448 - 1448
  • [38] LOW-PREVALENCE OF ANTI-HCV ANTIBODY AMONG ITALIAN CHILDREN
    ROMANO, L
    AZARA, A
    CHIARAMONTE, M
    DEMATTIA, D
    GIAMMANCO, A
    MOSCHEN, ME
    SCARPA, B
    STROFFOLINI, T
    ZANETTI, AR
    [J]. INFECTION, 1994, 22 (05) : 350 - 352
  • [39] ANTI-HCV ANTIBODY PREVALENCE - IN-CENTER VERSUS HOME HEMODIALYSIS
    GOROSTIDI, M
    AGUADO, S
    GOMEZ, E
    MARTINEZ, A
    OTERO, L
    GAGO, E
    ALVAREZGRANDE, J
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (01) : 207 - 208
  • [40] Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of Anti-HCV immunoglobulin g avidity index
    Klimashevskaya, S.
    Obriadina, A.
    Ulanova, T.
    Bochkova, G.
    Burkov, A.
    Araujo, A.
    Stramer, Susan L.
    Tobler, Leslie H.
    Busch, Michael P.
    Fields, Howard A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (10) : 3400 - 3403